Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea C Pinnix

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
JAMA Network Open|September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation TherapyChelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
American Journal of Hematology|May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaborationChan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Leukemia & Lymphoma|August 3, 2019
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function<sup>.</sup>Jillian R Gunther, Chanhyun Park, Bouthaina S Dabaja, et al.
Haematologica|January 11, 2020
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicityAdnan Elhammali, Behrang Amini, Ethan B Ludmir, et al.
Leukemia & Lymphoma|December 4, 2020
Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteriaLeslie K Ballas, Monika L Metzger, Sarah A Milgrom, et al.
American Journal of Hematology|November 23, 2016
Dorsal column myelopathy after intrathecal chemotherapy for leukemiaChelsea C Pinnix, Linda Chi, Elias J Jabbour, et al.
Advances in Radiation Oncology|November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the LungSusan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
Head & Neck|June 1, 2018
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphomaChelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
JAMA Network Open|September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation TherapyChelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
American Journal of Hematology|May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaborationChan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Leukemia & Lymphoma|August 3, 2019
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function<sup>.</sup>Jillian R Gunther, Chanhyun Park, Bouthaina S Dabaja, et al.
Haematologica|January 11, 2020
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicityAdnan Elhammali, Behrang Amini, Ethan B Ludmir, et al.
Leukemia & Lymphoma|December 4, 2020
Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteriaLeslie K Ballas, Monika L Metzger, Sarah A Milgrom, et al.
American Journal of Hematology|November 23, 2016
Dorsal column myelopathy after intrathecal chemotherapy for leukemiaChelsea C Pinnix, Linda Chi, Elias J Jabbour, et al.
Advances in Radiation Oncology|November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the LungSusan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
Head & Neck|June 1, 2018
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphomaChelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Pageof 16